Samsung BioLogics Update
Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...
522 Views
Merck Alliance Provides Stability to Deal With the Outcome of High Risk Alzheimer’s R&D in FY19
We upgrade Eisai Co Ltd (4523 JP) to “Equal-weight” after reviewing our model post FY17 (YE Mar-18) earnings, in light of the augmented peak sales...
245 Views
Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option. Link of this...
258 Views
The Week That Was In North Asia@Smartkarma: A Week of Cancellations & Baby Come Back
This past week was one of cancellations, highlighted by Trump cancelling his meeting with Kim Jong-Un and the Hyundai Motor Group cancelling the...
138 Views
FSC Chairman Speaks on Decision Framework
An article in the 24 May issue of BusinessKorea (link below) reports on a talk given by Financial Services Commission (FSC) Chairman Choi...
287 Views